Cre Recombinase
What is Cre Recombinase and Its Basic Function?
-
Cre recombinase (often abbreviated to Cre) is a Type I topoisomerase derived from the P1 bacteriophage.
-
It catalyzes site-specific recombination between 34 base pair (bp) recognition sites known as loxP sites.
-
This recombination:
-
Does not require energy cofactors
-
Rapidly reaches equilibrium between substrates and products
-
-
The outcome depends on the location and orientation of the loxP sites:
-
Same orientation on the same DNA: the intervening sequence is excised in circular form (deletion of "floxed" DNA).
-
Opposite orientation on the same DNA: the intervening sequence is inverted.
-
On different DNA molecules: can result in insertion or translocation.
-
-
The specificity of Cre/loxP is high due to the rarity of exact loxP sites in mammalian genomes, ensuring recombination is limited to introduced loxP sites.
Cre Recombinase Applications (Current Status)
Cre recombinase is widely used in gene and chromosome modification, serving as a universal genome editing tool in research, particularly in mouse models and increasingly in plants.
Key Applications:
-
Conditional Gene Knockout
Delete a DNA segment flanked by loxP sites in specific cells or tissues:
-
Controlled by tissue-specific or inducible promoters
-
Useful for genes causing embryonic lethality if knocked out globally
Examples:
-
Glucokinase-expressing tanycyte ablation in mice (Gck deletion)
-
Mouse model of pleomorphic liposarcoma via Cre-mediated silencing of Trp53, Rb1, and Pten
-
-
-
Conditional Transgenesis
Activate transgene expression by removing a loxP-flanked STOP sequence.
-
Selectable Marker Removal
Excise marker genes post-targeting to:
-
Avoid interference with nearby genes
-
Reuse vectors to make homozygous knockouts
-
-
Introducing Subtle Genetic Changes
Combine homologous recombination and Cre-mediated marker excision.
-
Creating Hypomorphic Alleles
Insert markers with cryptic splice sites to reduce gene expression.
-
Conditional Gene Repair
Rescue function of a disrupted gene in a lineage- or tissue-specific manner.
-
Generating Chromosomal Aberrations
Induce deletions, inversions, or translocations at defined loci.
-
Site-Specific DNA Insertion (Pop-In)
Insert DNA into target genomic loci using loxP recombination, sometimes with mutant lox sites (e.g., lox511) to promote insertion.
-
Cell Lineage Tracing
Use inducible Cre (e.g., Cre-ER) and Cre-dependent reporters to track cell fate.
-
Brain Research
Extensively used in neuroscience to study:
-
Neural circuits
-
Brain cell types
-
Cognition and behavior
NIH Blueprint has generated hundreds of Cre driver lines for this purpose.
-
-
Disease Modeling
Engineer models that mimic human disease with intact immune systems for preclinical drug testing.
-
Plant Genome Editing
Used for removal of transgenes or CRISPR components in plant systems. Helps in regeneration and fertility of edited plants.
-
In vitro Applications
-
Subcloning
-
Clone/vector engineering
-
Transduction into cultured cells, including ex vivo stem cells
-
Excellgen’s Cre Recombinase
Products:
-
TAT-Cre (EG-1021, EG-1001)
-
Lyophilized TAT-Cre (EG-8)
Features:
-
Cell-permeant fusion Cre protein purified from E. coli
-
Includes TAT peptide and nuclear localization signal (NLS) for efficient delivery
Applications:
-
In vitro loxP recombination for vector engineering
-
Transduction into cultured cells
-
In vivo recombination by direct injection in mice (e.g., brain or muscle)
Current Status and Future Opportunities
Current Status
-
Widely adopted for precise genetic manipulation
-
Tissue-specific and inducible Cre lines are common
-
Used to create sophisticated animal disease models
-
Key tool in plant gene editing, especially for removing other editing elements
Future Opportunities
-
Develop more reliable and specific Cre transgenic lines:
-
Use better promoters
-
Employ site-specific knock-in strategies
-
-
Enhance temporal control:
- Improve inducible systems like Cre-ER
-
Improve recombination efficiency and reduce off-target effects:
-
Particularly important for plant systems
-
Address effects of DNA methylation
-
-
Expand disease modeling applications for novel therapy testing
-
Broaden use in plant biotechnology for more precise gene control
-
As CRISPR advances, Cre-lox remains valuable for conditional/site-specific modifications
-
Demand continues to rise with growth in molecular biology and biotech sectors, even if it's considered part of broader tech categories